Last updated: 11 March 2024 at 8:42pm EST

Lawrence Hineline Net Worth




The estimated Net Worth of Lawrence J. Hineline is at least $11.9 Milione dollars as of 6 March 2024. Mr. Hineline owns over 13,132 units of Intra-Cellular Therapies Inc stock worth over $981,223 and over the last 10 years he sold ITCI stock worth over $8,741,317. In addition, he makes $2,193,530 as Chief Financial Officer, Senior Vice President - Finance, Treasurer e Assistant Secretary at Intra-Cellular Therapies Inc.

Mr. Hineline ITCI stock SEC Form 4 insiders trading

Lawrence has made over 31 trades of the Intra-Cellular Therapies Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he sold 23,253 units of ITCI stock worth $1,542,139 on 7 March 2024.

The largest trade he's ever made was exercising 175,000 units of Intra-Cellular Therapies Inc stock on 21 December 2021 worth over $2,941,750. On average, Lawrence trades about 20,602 units every 79 days since 2014. As of 6 March 2024 he still owns at least 13,132 units of Intra-Cellular Therapies Inc stock.

You can see the complete history of Mr. Hineline stock trades at the bottom of the page.





Lawrence Hineline biography

Lawrence J. Hineline serves as Chief Financial Officer, Senior Vice President - Finance, Treasurer, Assistant Secretary of the Company. Mr. Hineline has served as Senior Vice President of Finance of the Company since January 2019 and Chief Financial Officer and Treasurer of the Company since the Merger in August 2013. He also served as Vice President of Finance of the Company from the Merger in August 2013 to December 2018. He has served as Vice President of Finance, Chief Financial Officer and Secretary of ITI since June 2002. Mr. Hineline also served as the Secretary of the Company from August 2013 until September 2014. From December 2000 to November 2003, Mr. Hineline was the Vice President of Finance and Chief Financial Officer of Functional Genetics, Inc. Prior to that, Mr. Hineline served as the Vice President of Finance of North American Vaccine, Inc. and its predecessor companies from 1993 to 2000, and he served as Corporate Controller from 1989 to 1993. During this time, Mr. Hineline oversaw the growth of the accounting function and its systems for the company that emerged as a start-up and was later acquired by Baxter Health Care. Mr. Hineline is a licensed CPA in the State of Maryland and received his Bachelor’s Degree from the University of Maryland Baltimore County.

What is the salary of Lawrence Hineline?

As the Chief Financial Officer, Senior Vice President - Finance, Treasurer e Assistant Secretary of Intra-Cellular Therapies Inc, the total compensation of Lawrence Hineline at Intra-Cellular Therapies Inc is $2,193,530. There are 3 executives at Intra-Cellular Therapies Inc getting paid more, with Sharon Mates having the highest compensation of $4,724,560.



How old is Lawrence Hineline?

Lawrence Hineline is 63, he's been the Chief Financial Officer, Senior Vice President - Finance, Treasurer e Assistant Secretary of Intra-Cellular Therapies Inc since 2019. There are 7 older and 9 younger executives at Intra-Cellular Therapies Inc. The oldest executive at Intra-Cellular Therapies Inc is Richard Lerner, 81, who is the Independent Director.

What's Lawrence Hineline's mailing address?

Lawrence's mailing address filed with the SEC is C/O INTRA-CELLULAR THERAPIES, INC., 430 EAST 29TH STREET, NEW YORK, NY, 10016.

Insiders trading at Intra-Cellular Therapies Inc

Over the last 11 years, insiders at Intra-Cellular Therapies Inc have traded over $77,703,646 worth of Intra-Cellular Therapies Inc stock and bought 3,068,522 units worth $52,322,638 . The most active insiders traders include Rory B Riggs, Joel S Marcus e Christopher D Alafi. On average, Intra-Cellular Therapies Inc executives and independent directors trade stock every 17 days with the average trade being worth of $2,787,280. The most recent stock trade was executed by Sharon Mates on 29 August 2024, trading 70,000 units of ITCI stock currently worth $891,100.



What does Intra-Cellular Therapies Inc do?

intra-cellular therapies is a company based out of 3960 broadway, new york, new york, united states.



What does Intra-Cellular Therapies Inc's logo look like?

Intra-Cellular Therapies Inc logo

Complete history of Mr. Hineline stock trades at Intra-Cellular Therapies Inc

Data
#
Ditta
Persona
Trans.
Transazione
Azioni Prezzo per azione Prezzo totale Azioni dopo Fonte
7 Mar 2024 Lawrence J. Hineline
SVP of Finance e CFO
Vendita 23,253 $66.32 $1,542,139
7 Mar 2024
0
6 Mar 2024 Lawrence J. Hineline
SVP of Finance e CFO
Opzione 13,132 $66.03 $867,106
6 Mar 2024
13,132
23 Feb 2024 Lawrence J. Hineline
SVP of Finance e CFO
Opzione 13,337 $16.27 $216,993
23 Feb 2024
5,882
1 Feb 2024 Lawrence J. Hineline
SVP of Finance e CFO
Vendita 11,183 $66.62 $745,011
1 Feb 2024
0
14 Jun 2023 Lawrence J. Hineline
SVP of Finance e CFO
Opzione 81,854 $42.30 $3,462,424
14 Jun 2023
81,854
9 Mar 2023 Lawrence J. Hineline
SVP of Finance e CFO
Vendita 21,245 $43.55 $925,220
9 Mar 2023
0
23 Feb 2023 Lawrence J. Hineline
SVP of Finance e CFO
Opzione 7,455 $47.65 $355,231
23 Feb 2023
7,455
18 Feb 2023 Lawrence J. Hineline
SVP of Finance e CFO
Opzione 64,411 $10.67 $687,265
18 Feb 2023
10,443
21 Sep 2022 Lawrence J. Hineline
SVP of Finance e CFO
Opzione 65,164 $15.47 $1,008,087
21 Sep 2022
65,164
23 Feb 2022 Lawrence J. Hineline
SVP of Finance e CFO
Opzione 7,454 $53.05 $395,435
23 Feb 2022
7,454
18 Feb 2022 Lawrence J. Hineline
SVP of Finance e CFO
Opzione 10,443 $56.63 $591,387
18 Feb 2022
10,443
8 Jan 2022 Lawrence J. Hineline
SVP of Finance e CFO
Opzione 19,639 $43.03 $845,066
8 Jan 2022
19,639
21 Dec 2021 Lawrence J. Hineline
SVP of Finance e CFO
Opzione 175,000 $16.81 $2,941,750
21 Dec 2021
175,000
18 Feb 2021 Lawrence J. Hineline
SVP of Finance e CFO
Opzione 10,442 $39.02 $407,447
18 Feb 2021
10,442
8 Jan 2021 Lawrence J. Hineline
SVP of Finance e CFO
Opzione 19,638 $32.95 $647,072
8 Jan 2021
19,638
3 Jan 2021 Lawrence J. Hineline
SVP of Finance e CFO
Opzione 16,160 $31.80 $513,888
3 Jan 2021
16,160
11 Nov 2020 Lawrence J. Hineline
SVP of Finance e CFO
Vendita 28,034 $25.41 $712,344
11 Nov 2020
0
9 Sep 2020 Lawrence J. Hineline
SVP of Finance e CFO
Vendita 41,983 $31.14 $1,307,351
9 Sep 2020
8,034
9 Jan 2020 Lawrence J. Hineline
SVP of Finance e CFO
Vendita 19,638 $26.16 $513,730
9 Jan 2020
18,800
6 Jan 2020 Lawrence J. Hineline
SVP of Finance e CFO
Vendita 21,458 $30.29 $649,963
6 Jan 2020
18,800
31 Dec 2019 Lawrence J. Hineline
SVP of Finance e CFO
Opzione 21,458 $34.31 $736,224
31 Dec 2019
40,258
23 Dec 2019 Lawrence J. Hineline
SVP of Finance e CFO
Vendita 15,032 $25.50 $383,316
23 Dec 2019
19,800
27 Feb 2019 Lawrence J. Hineline
SVP of Finance e CFO
Opzione 10,400 $2.74 $28,496
27 Feb 2019
26,232
4 Jan 2019 Lawrence J. Hineline
SVP of Finance e CFO
Vendita 24,566 $11.58 $284,474
4 Jan 2019
17,032
15 Feb 2018 Lawrence J. Hineline
SVP of Finance e CFO
Vendita 49,700 $20.02 $994,994
15 Feb 2018
17,032
5 Jan 2017 Lawrence J. Hineline
SVP of Finance e CFO
Vendita 1,918 $16.58 $31,800
5 Jan 2017
63,389
24 Nov 2015 Lawrence J. Hineline
SVP of Finance e CFO
Opzione 47,500 $1.23 $58,425
24 Nov 2015
62,200
24 Nov 2015 Lawrence J. Hineline
SVP of Finance e CFO
Vendita 5,000 $55.00 $275,000
24 Nov 2015
59,700
8 Dec 2014 Lawrence J. Hineline
SVP of Finance e CFO
Vendita 22,500 $16.71 $375,975
8 Dec 2014
64,700
2 Dec 2014 Lawrence J. Hineline
SVP of Finance e CFO
Opzione 37,200 $0.50 $18,600
2 Dec 2014
87,200
8 Sep 2014 Lawrence J. Hineline
SVP of Finance e CFO
Opzione 300 $0.50 $150
8 Sep 2014
50,300


Intra-Cellular Therapies Inc executives and stock owners

Intra-Cellular Therapies Inc executives and other stock owners filed with the SEC include: